#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14308	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2175	655.0	0	.	n	.	0	C1525T	SNP	1525	1525	C	1793	1793	T	700	T,C	305,329	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14308	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2175	655.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1452	1452	C	788	C,T	742,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14308	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2175	655.0	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1680	1680	T	792	TGGGGG,TGGGGGG	543,168	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25970	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3622	715.5	0	.	n	.	0	T695C	SNP	695	695	T	1080	1080	C	800	C	742	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25970	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3622	715.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	2023	2023	G	819	G	760	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25970	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3622	715.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2356	2356	C	819	C,T	757,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25970	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3622	715.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2430	2430	A	808	A	757	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25970	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3622	715.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2982	2982	C	832	C,A	771,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1672	folP	855	855	100.0	folP.l15.c17.ctg.1	1615	103.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1126	1128	AGC	191;189;189	A,C;G;C	176,1;176;173	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4780	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3506	136.0	1	SNP	p	S91F	1	.	.	271	273	TTC	549	551	TTC	165;166;166	T;T;C	158;159;160	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4780	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3506	136.0	1	SNP	p	D95G	1	.	.	283	285	GGC	561	563	GGC	164;164;164	G;G;C	151;154;155	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4780	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3506	136.0	1	SNP	p	G95N	0	.	.	283	285	GGC	561	563	GGC	164;164;164	G;G;C	151;154;155	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1456	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1312	110.3	0	.	p	.	0	F184L	NONSYN	550	552	TTC	872	874	TTG	176;176;177	T;T;G	163;168;167	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1456	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1312	110.3	1	SNP	p	G45D	0	.	.	133	135	GGC	455	457	GGC	196;193;195	G,A;G;C	175,1;175;176	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	762	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	959	78.5	0	.	n	.	0	A197.	DEL	197	197	A	566	566	A	169	A	160	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5342	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3031	175.8	1	SNP	p	D86N	0	.	.	256	258	GAC	610	612	GAC	206;206;207	G,A;A;C	194,1;187;194	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5342	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3031	175.8	1	SNP	p	R87W	0	.	.	259	261	CGT	613	615	CGT	206;205;205	C;G;T	196;195;191	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5342	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3031	175.8	1	SNP	p	S87R	1	.	.	259	261	CGT	613	615	CGT	206;205;205	C;G;T	196;195;191	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5342	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3031	175.8	1	SNP	p	R87I	0	.	.	259	261	CGT	613	615	CGT	206;205;205	C;G;T	196;195;191	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5342	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3031	175.8	1	SNP	p	S88P	0	.	.	262	264	TCC	616	618	TCC	206;205;205	T;C;C	195;194;192	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3762	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2623	143.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1532	1534	GGC	185;182;183	G,C;G;C	170,1;166;169	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3662	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	151.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1212	1214	GCA	187;191;192	G;C;A	174;174;181	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3662	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	151.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1215	1217	ATC	193;195;197	A;T;C	179;184;181	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3662	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	151.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1227	1229	GTG	192;191;189	G;T;G	181;181;180	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3662	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	151.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1227	1229	GTG	192;191;189	G;T;G	181;181;180	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3662	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	151.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1731	1733	ACC	172;173;174	A,G;C;C	156,1;161;163	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3662	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	151.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1785	1787	GCG	174;173;172	G;C;G,C	159;142;147,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3662	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	151.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1785	1787	GCG	174;173;172	G;C;G,C	159;142;147,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3662	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	151.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1908	1910	AGC	168;165;164	A;G;C	151;150;148	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3662	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	151.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1917	1919	GGC	160;157;156	G,T;G;C	145,1;143;141	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3662	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	151.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1935	1937	CCG	148;150;148	C,G;C;G	108,6;110;107	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5464	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3056	178.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1664	1666	CCG	206;205;202	C;C;G	173;185;172	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2142	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1769	120.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	516	516	C	184	C	169	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2640	porB1b	1047	1047	98.85	porB1b.l15.c17.ctg.1	1443	181.3	0	.	p	.	0	T26A	NONSYN	76	78	ACC	327	329	GCC	225;222;223	G,A;C;C	213,1;209;211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2640	porB1b	1047	1047	98.85	porB1b.l15.c17.ctg.1	1443	181.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	363	365	GAA	228;230;229	G;A;A	211;213;212	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2640	porB1b	1047	1047	98.85	porB1b.l15.c17.ctg.1	1443	181.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	651	653	GAT	216;214;216	G;A;T	204;200;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2640	porB1b	1047	1047	98.85	porB1b.l15.c17.ctg.1	1443	181.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	774	776	TCA	208;208;209	T,C;C;A	197,1;199;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2640	porB1b	1047	1047	98.85	porB1b.l15.c17.ctg.1	1443	181.3	0	.	p	.	0	D212A	NONSYN	634	636	GAT	885	887	GCT	229;226;226	G;C,A;T	215;213,1;211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2640	porB1b	1047	1047	98.85	porB1b.l15.c17.ctg.1	1443	181.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	903	905	GTC	235;234;233	G,A;T;C	223,1;223;225	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2640	porB1b	1047	1047	98.85	porB1b.l15.c17.ctg.1	1443	181.3	0	.	p	.	0	S220N	NONSYN	658	660	AGC	909	911	AAC	241;238;240	A;A,G;C	231;222,1;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2640	porB1b	1047	1047	98.85	porB1b.l15.c17.ctg.1	1443	181.3	0	.	p	.	0	Y254C	NONSYN	760	762	TAT	1011	1013	TGT	228;225;223	T;G,A;T	211;208,1;208	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2640	porB1b	1047	1047	98.85	porB1b.l15.c17.ctg.1	1443	181.3	1	SNP	p	G120K	1	.	.	358	360	AAG	609	611	AAG	207;204;202	A;A;G	194;191;190	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2640	porB1b	1047	1047	98.85	porB1b.l15.c17.ctg.1	1443	181.3	1	SNP	p	D121N	0	.	.	361	363	GAC	612	614	GAC	202;202;204	G;A;C	190;189;191	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2640	porB1b	1047	1047	98.85	porB1b.l15.c17.ctg.1	1443	181.3	1	SNP	p	A121D	1	.	.	361	363	GAC	612	614	GAC	202;202;204	G;A;C	190;189;191	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10558	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4935	213.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1230	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1015	120.2	1	SNP	p	V57M	1	.	.	169	171	ATG	561	563	ATG	244;245;244	A;T;G	227;231;230	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
